23 May 2013
Keywords: sciele, completes, ph, iii, drool-drug, trial, drugmaker
Article | 14 July 2008
US drugmaker Sciele Pharma has completed a Phase III safety trial of liquid formulation gylcopyrrolate in the treatment of moderate-to-severe
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
22 May 2013
© 2013 thepharmaletter.com